The study includes the use of saracatinib, an investigational drug originally developed to treat certain types of cancers, in the treatment of ipf in a phase 1b/2a clinical trial. This is a phase 3 trial to evaluate the efficacy and safety of 30 milligrams (mg)/kilogram (kg) intravenous (iv) infusions of pamrevlumab.
Fibroneerā¢ phase iii program initiated globally to evaluate bi 1015550, a novel investigational phosphodiesterase 4b (pde4b) inhibitor, in idiopathic pulmonary fibrosis (ipf) and other. A study to test how effective and safe glpg1690 is for subjects with idiopathic pulmonary fibrosis (ipf) when used.
The Following Clinical Trial Are The Most Recent Offered By Clinicaltrials.gov.
Zelasudil, an experimental treatment for idiopathic pulmonary fibrosis (ipf) thatās now being tested in clinical trials, has been granted orphan drug status by the u.s.
Boehringer Ingelheimās Bi 1015550āAn Investigational Phosphodiesterase 4B (Pde4B) Inhibitorā Has The Potential To Address Both Pulmonary FibrosisāAn Irreversible Scarring.
Idiopathic pulmonary fibrosis (ipf) carries significant mortality and unpredictable progression, with limited therapeutic options.
Images References :
Ipf Clinical Trials 2024 Ipf Research Studies Recruiting Patients In 2024 Need Your Help.
The following clinical trial are the most recent offered by clinicaltrials.gov.
Top 10 Ipf Clinical Trials [2024 Studies] Power, Clinical Trials, Fda, Ema, Pmda Approvals, Therapies, Growth Opportunities, And Companies By Delveinsight.
Boehringer ingelheimās bi 1015550āan investigational phosphodiesterase 4b (pde4b) inhibitorā has the potential to address both pulmonary fibrosisāan irreversible scarring.
